GlassScriptPhysician profile
Scott K Stephenson
NPI 1669459095
$5,407.55
in general payments reported to CMS, 2019-2025
38 companies · $845 in 2025
The $845 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,222 · 2020: $692 · 2021: $344 · 2022: $559 · 2023: $850 · 2024: $895 · 2025: $845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,570 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,570.41 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $896.43 | 2020-2025 | Gallant, Assurity, Jot Dx |
| Pfizer INC. | $724.69 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $608.36 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $443.38 | 2022-2025 | Verquvo, Capvaxive |
| Amgen INC. | $416.41 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $313.94 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $290.57 | 2019-2024 | Lifevest |
| Sanofi-Aventis U.S. LLC | $236.52 | 2019-2023 | |
| Boston Scientific Corporation | $228.90 | 2019-2025 | Watchman Access System, Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $196.33 | 2019-2025 | Jardiance |
| Biotronik INC. | $127.34 | 2023-2024 | Biomonitor, Rivacor 7 Dr-T, Renamic Neo |
| Astellas Pharma US INC | $123.42 | 2019-2020 | |
| Amarin Pharma, INC. | $85.75 | 2019-2020 | |
| Scpharmaceuticals INC. | $78.99 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $64.01 | 2024 | Camzyos, Eliquis |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $56.50 | 2024-2025 | |
| Itamar Medical INC | $51.79 | 2022-2023 | Watchpatone |
| Gilead Sciences, INC. | $49.75 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $40.75 | 2020-2024 | Farxiga |
| Novo Nordisk INC | $33.49 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $29.41 | 2023-2025 | Zepbound, Mounjaro, Emgality |
| Regeneron Healthcare Solutions, INC. | $25.56 | 2019 | |
| Philips North America LLC | $24.82 | 2024 | (Ck7) Extended Holter |
| Edwards Lifesciences Corporation | $23.27 | 2019 | |
| Bardy Diagnostics, INC. | $20.67 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $20.13 | 2025 | Opsumit |
| Esperion Therapeutics, INC. | $19.94 | 2022 | |
| Dexcom, INC. | $19.27 | 2025 | Dexcom G6 Transmitter |
| Heartflow, INC. | $18.67 | 2024 | |
| Glaxosmithkline, LLC. | $17.73 | 2025 | Arexvy, Shingrix |
| Lexicon Pharmaceuticals, INC. | $17.37 | 2023 | Inpefa |
| Baxter Healthcare | $16.68 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Exact Sciences Corporation | $15.88 | 2025 | Cologuard Collection Kit |
| Kiniksa Pharmaceuticals, LTD. | $15.79 | 2023 | Arcalyst |
| Vital Connect, INC | $15.73 | 2022 | |
| Medtronic, INC. | $14.51 | 2025 | Micra |
| G Medical Diagnostic Services, INC. | $13.69 | 2024 | Cardiac Monitoring Suite |
| Elutia, INC. | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Stephenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.